Heptane

Heptane

SCHEMBL5203374

CC(C)O.CCCCCCC.O=CO

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.48
ADH1B P00325 2/20 0.46
ADH1C P00326 2/20 0.46
ADH1A P07327 2/20 0.46
ADH4 P08319 2/20 0.46
ADH7 P40394 2/20 0.46
TRPA1 O75762 1/20 0.45
DDAH1 O94760 1/20 0.45
GAPDH P04406 1/20 0.45
MAPT P10636 1/20 0.45
GPR84 Q9NQS5 3/20 0.44
THRB P10828 1/20 0.44
SPHK1 Q9NYA1 1/20 0.44
FFAR1 O14842 1/20 0.44
EPHX1 P07099 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hexane SCHEMBL720450 0.97 TRPA1 (0.46) TSHRADH1BADH1CADH1AADH4
Heptane SCHEMBL7200232 0.89 SPHK1 (0.42) TSHRADH1BADH1CADH1AADH4
Undecane SCHEMBL27602336 0.88 TSHR (0.58) TSHRADH1BADH1CADH1AADH4
Decane SCHEMBL30414302 0.88 TSHR (0.58) TSHRADH1BADH1CADH1AADH4
Decane SCHEMBL28167744 0.88 TSHR (0.58) TSHRADH1BADH1CADH1AADH4
Heptane SCHEMBL9572062 0.88 TSHR (0.58) TSHRADH1BADH1CADH1AADH4
Octane SCHEMBL2485910 0.88 TSHR (0.58) TSHRADH1BADH1CADH1AADH4
Dodecane SCHEMBL28752290 0.88 TSHR (0.58) TSHRADH1BADH1CADH1AADH4
Formic Acid SCHEMBL28813257 0.88 TSHR (0.58) TSHRADH1BADH1CADH1AADH4
Tridecane SCHEMBL28326257 0.88 TSHR (0.58) TSHRADH1BADH1CADH1AADH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1150996-B1 NEW AMIDINOBENZYLAMINE DERIVATIVES AND THEIR USE AS THROMBIN INHIBITORS ASTRAZENECA AB (SE) 2007-11-21 EP disclosed
US-6599894-B1 Competitive inhibitors of trypsin-like proteases, such as thrombin, and in treatment of conditions where inhibition of thrombin is required (e.g. thrombosis) or as anticoagulants AstŕaZeneca AB (SE) 2003-07-29 US disclosed